Affinity enhancement of HER2-binding Z(HER2:342) affibody via rational design approach: a molecular dynamics study

References

• Adams, G. P., & Weiner, L. M. (2005). Monoclonal antibody therapy of cancer. Natural Biotechnology, 23, 1147–1157.
   Google Scholar
• Alexis, F., Basto, P., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Zhang, L., Pridgen, E., … Farokhzad, O. C. (2008). HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem, 3, 1839–1843.
   PubMed Web of Science ®Google Scholar
• Awada, A., Bozovic-Spasojevic, I., & Chow, L. (2012). New therapies in HER2-positive breast cancer: A major step towards a cure of the disease? Cancer Treatment Reviews, 38, 494–504.
   PubMed Web of Science ®Google Scholar
• Barnes, C. J., Bagheri-Yarmand, R., Mandal, M., Yang, Z., Clayman, G. L., Hong, W. K., & Kumar, R. (2003). Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Molecular Cancer Therapeutics, 2, 345–351.
   PubMed Web of Science ®Google Scholar
• Bottomley, S. P., Popplewell, A. G., Scawen, M., Wan, T., Sutton, B. J., & Gore, M. G. (1994). The stability and unfolding of an IgG binding protein based upon the B domain of protein A from Staphylococcus aureus probed by tryptophan substitution and fluorescence spectroscopy. Protein Engineering, 7, 1463–1470.
   PubMedGoogle Scholar
• Camacho, C. J., & Zhang, C. (2005). FastContact: Rapid estimate of contact and binding free energies. Bioinformatics, 21, 2534–2536.
   PubMed Web of Science ®Google Scholar
• Carpenter, G. (2000). The EGF receptor: A nexus for trafficking and signaling. BioEssays, 22, 697–707.
   PubMed Web of Science ®Google Scholar
• Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., … Shepard, H. M. (1992). Humanization of an anti-p185HER2 antibody for human cancer therapy. Proceedings of the National Academy of Sciences USA, 89, 4285–4289.
   PubMed Web of Science ®Google Scholar
• Cho, H. S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., Jr, & Leahy, D. J. (2003). Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature, 421, 756–760.
   PubMed Web of Science ®Google Scholar
• Clark, L. A., Boriack-Sjodin, P. A., Eldredge, J., Fitch, C., Friedman, B., Hanf, K. J., … Van Vlijmen, H. (2006). Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Science, 15, 949–960.
   PubMed Web of Science ®Google Scholar
• Cochran, F. V., Wu, S. P., Wang, W., Nanda, V., Saven, J. G., Therien, M. J., & DeGrado, W. F. (2005). Computational de novo design and characterization of a four-helix bundle protein that selectively binds a nonbiological cofactor. Journal of American Chemistry Society, 127, 1346–1347.
   PubMed Web of Science ®Google Scholar
• Dahiyat, B. I., & Mayo, S. L. (1997). De novo protein design: Fully automated sequence selection. Science, 278, 82–87.
   PubMed Web of Science ®Google Scholar
• Delano, W. L. (2002). The PyMOL molecular graphics system. Palo Alto, CA: DeLano Scientific.
   Google Scholar
• Desjarlais, J. R., & Handel, T. M. (1995). De novo design of the hydrophobic cores of proteins. Protein Science, 4, 2006–2018.
   PubMed Web of Science ®Google Scholar
• Eigenbrot, C., Ultsch, M., Dubnovitsky, A., Abrahmsen, L., & Hard, T. (2010). Structural basis for high-affinity HER2 receptor binding by an engineered protein. Proceedings of the National Academy of Sciences USA, 107, 15039–15044.
   PubMed Web of Science ®Google Scholar
• Ekerljung, L., Lennartsson, J., & Gedda, L. (2012). The HER2-binding affibody molecule (Z(HER2ratio342))(2) increases radiosensitivity in SKBR-3 cells. PLoS ONE, 7, e49579.
   PubMedGoogle Scholar
• Ekerljung, L., Lindborg, M., Gedda, L., Frejd, F. Y., Carlsson, J., & Lennartsson, J. (2008). Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line. Biochemical and Biophysical Research Communications, 377, 489–494.
   PubMed Web of Science ®Google Scholar
• Friedman, M., & Stahl, S. (2009). Engineered affinity proteins for tumour-targeting applications. Biotechnology and Applied Biochemistry, 53, 1–29.
   PubMed Web of Science ®Google Scholar
• Grant, S., Qiao, L., & Dent, P. (2002). Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Frontiers in Bioscience, 7, d376–389.
   PubMed Web of Science ®Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 18, 2714–2723.
   PubMed Web of Science ®Google Scholar
• Harari, P. M. (2004). Epidermal growth factor receptor inhibition strategies in oncology. Endocrine-Related Cancer, 11, 689–708.
   PubMed Web of Science ®Google Scholar
• Havranek, J. J., & Harbury, P. B. (2003). Automated design of specificity in molecular recognition. Nature Structral Biology, 10, 45–52.
   PubMedGoogle Scholar
• Heinig, M., & Frishman, D. (2004). STRIDE: A web server for secondary structure assignment from known atomic coordinates of proteins. Nucleic Acids Research, 32, W500–502.
   PubMed Web of Science ®Google Scholar
• Horovitz, A., Serrano, L., Avron, B., Bycroft, M., & Fersht, A. R. (1990). Strength and co-operativity of contributions of surface salt bridges to protein stability. Journal of Molecular Biology, 216, 1031–1044.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 27–38.
   Google Scholar
• Joachimiak, L. A., Kortemme, T., Stoddard, B. L., & Baker, D. (2006). Computational design of a new hydrogen bond network and at least a 300-fold specificity switch at a protein-protein interface. Journal of Molecular Biology, 361, 195–208.
   PubMed Web of Science ®Google Scholar
• Lee, S. B., Hassan, M., Fisher, R., Chertov, O., Chernomordik, V., Kramer-Marek, G., … Capala, J. (2008). Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clinical Cancer Research, 14, 3840–3849.
   PubMed Web of Science ®Google Scholar
• Lippow, S. M., Wittrup, K. D., & Tidor, B. (2007). Computational design of antibody-affinity improvement beyond in vivo maturation. Nature Biotechnology, 25, 1171–1176.
   PubMed Web of Science ®Google Scholar
• Lofblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Stahl, S., & Frejd, F. Y. (2010). Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Letters, 584, 2670–2680.
   PubMed Web of Science ®Google Scholar
• Musafia, B., Buchner, V., & Arad, D. (1995). Complex salt bridges in proteins: Statistical analysis of structure and function. Journal of Molecular Biology, 254, 761–770.
   PubMed Web of Science ®Google Scholar
• Nilsson, B., Moks, T., Jansson, B., Abrahmsen, L., Elmblad, A., Holmgren, E., … Uhlen, M. (1987). A synthetic IgG-binding domain based on staphylococcal protein A. Protein Engineering, 1, 107–113.
   PubMedGoogle Scholar
• Nord, K., Gunneriusson, E., Ringdahl, J., Stahl, S., Uhlen, M., & Nygren, P. A. (1997). Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nature Biotechnology, 15, 772–777.
   PubMed Web of Science ®Google Scholar
• Orlova, A., Magnusson, M., Eriksson, T. L., Nilsson, M., Larsson, B., Hoiden-Guthenberg, I., … Nilsson, F. Y. (2006). Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Research, 66, 4339–4348.
   PubMed Web of Science ®Google Scholar
• Persson, M., Gedda, L., Lundqvist, H., Tolmachev, V., Nordgren, H., Malmstrom, P. U., & Carlsson, J. (2007). [177Lu]pertuzumab: Experimental therapy of HER-2-expressing xenografts. Cancer Research, 67, 326–331.
   PubMed Web of Science ®Google Scholar
• Pickersgill, R. W. (1988). A rapid method of calculating charge-charge interaction energies in proteins. Protein Engineering, 2, 247–248.
   PubMedGoogle Scholar
• Reina, J., Lacroix, E., Hobson, S. D., Fernandez-Ballester, G., Rybin, V., Schwab, M. S., … Gonzalez, C. (2002). Computer-aided design of a PDZ domain to recognize new target sequences. Nature Structral Biology, 9, 621–627.
   PubMedGoogle Scholar
• Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984). The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature, 312, 513–516.
   PubMed Web of Science ®Google Scholar
• Shepard, H. M., Jin, P., Slamon, D. J., Pirot, Z., & Maneval, D. C. (2008). Herceptin. Handbook of Experimental Pharmacology, 183–219.
   PubMedGoogle Scholar
• Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987). Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177–182.
   PubMed Web of Science ®Google Scholar
• Sood, V. D., & Baker, D. (2006). Recapitulation and design of protein binding peptide structures and sequences. Journal of Molecular Biology, 357, 917–927.
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718.
   PubMed Web of Science ®Google Scholar
• Wells, A. (1999). EGF receptor. International Journal of Biochemistry and Cell Biology, 31, 637–643.
   PubMed Web of Science ®Google Scholar
• Yarden, Y. (2001a). Biology of HER2 and its importance in breast cancer. Oncology, 61(Suppl 2), 1–13.
   PubMed Web of Science ®Google Scholar
• Yarden, Y. (2001b). The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. European Journal of Cancer, 37, S3–8. Suppl 4.
   Web of Science ®Google Scholar
• Yarden, Y., & Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nature Reviews Molecular Cell Biology, 2, 127–137.
   PubMed Web of Science ®Google Scholar
• Yin, J., Bowen, D., & Southerland, W. M. (2006). Barnase thermal titration via molecular dynamics simulations: Detection of early denaturation sites. Journal of Molecular Graphics Modelling, 24, 233–243.
   PubMed Web of Science ®Google Scholar
• Zhang, C., Vasmatzis, G., Cornette, J. L., & DeLisi, C. (1997). Determination of atomic desolvation energies from the structures of crystallized proteins. Journal of Molecular Biology, 267, 707–726.
   PubMed Web of Science ®Google Scholar